Physician profile
Jason A Berger
NPI 1487027991
$344,466.88
in general payments reported to CMS, 2019-2025
18 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,140 · 2022: $87K · 2023: $230K · 2024: $11K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $188K · Travel and Lodging: $48K · Consulting Fee: $11K · Food and Beverage: $9,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $187,745.00 |
| Travel and Lodging | $47,579.19 |
| Consulting Fee | $11,270.00 |
| Food and Beverage | $9,607.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $326,605.31 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $14,783.21 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
| Astrazeneca Pharmaceuticals Lp | $1,024.95 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $338.21 | 2021-2024 | Xarelto |
| Abbott Laboratories | $330.86 | 2021-2022 | |
| Prenosis INC. | $200.00 | 2025 | Sepsis Immunoscore |
| Boston Scientific Corporation | $136.96 | 2025 | Farapulse |
| Novo Nordisk INC | $124.88 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $120.74 | 2021 | |
| Neurocrine Biosciences, INC. | $119.91 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $119.23 | 2021 | |
| Abiomed | $117.82 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.25 | 2021 | |
| Heron Therapeutics, INC. | $89.82 | 2022 | |
| Janssen Scientific Affairs, LLC | $86.94 | 2024 | Xarelto |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.29 | 2021 | |
| Gilead Sciences, INC. | $68.99 | 2021-2024 | |
| Pfizer INC. | $25.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.